Background pattern
Aquipta 60 mg comprimidos

Aquipta 60 mg comprimidos

About the medicineAbout the medication

Introduction

Prospect: information for the patient

AQUIPTA 10 mg tablets

AQUIPTA 60 mg tablets

atogepant

This medicine is subject to additional monitoring, which will expedite the detection of new information about its safety. You can contribute by reporting any adverse effects you may experience. The final part of section 4 includes information on how to report these adverse effects.

Read this prospect carefully before starting to take this medicine, because it contains important information for you.

  • Keep this prospect, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed only for you, and you must not give it to other people even if they have the same symptoms as you, as it may harm them.
  • If you experience adverse effects, consult your doctor or pharmacist, even if they do not appear in this prospect. See section 4.

1. What is AQUIPTA and how is it used

AQUIPTA contains the active ingredient atogepant. AQUIPTA is used to prevent migraine in adults who experience at least 4 days of migraine per month.

AQUIPTA is believed to block the activity of the calcitonin gene-related peptide receptor family (CGRP), which has been linked to migraine.

2. What you need to know before starting AQUIPTA

Do not take AQUIPTA

  • if you are allergic to atogepant or any of the other ingredients in this medication (listed in section 6).

Warnings and precautions

Stop taking AQUIPTA and inform your doctor immediately if you experience any symptoms of an allergic reaction such as:

• difficulty breathing

• facial swelling

• rash, itching, or urticaria

Some of these symptoms may occur within 24 hours after the first use. In some cases, they may occur several days after taking AQUIPTA.

Consult your doctor, pharmacist, or nurse before starting to take AQUIPTA if you have severe liver problems.

Children and adolescents

Do not administer this medication to children or adolescents under 18 years of age, as AQUIPTA has not been studied in this age group.

Other medications and AQUIPTA

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. Some medications may increase the risk of adverse effects (see section 4).

The following list contains examples of medications that may require your doctor to reduce your AQUIPTA dose:

  • ketoconazole, itraconazole, clarithromycin, rifampicin (medications used to treat fungal or bacterial infections);
  • ritonavir (medication used to treat HIV);
  • ciclosporin (medication that affects your immune system).

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor before using this medication.

Do not take AQUIPTA if you are pregnant. If you are a woman and may become pregnant, use suitable contraceptive methods during AQUIPTA treatment.

Do not take AQUIPTA if you are breastfeeding or plan to breastfeed. You and your doctor must decide whether to breastfeed or take AQUIPTA.

Driving and operating machinery

AQUIPTA may cause drowsiness. Do not drive or operate machinery if it affects you.

AQUIPTA contains sodium

AQUIPTA 10 mg tablets

This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".

AQUIPTA 60 mg tablets

This medication contains 31.5 mg of sodium (main component of table salt/for cooking) in each tablet. This is equivalent to 1.6% of the maximum daily sodium intake recommended for an adult.

3. How to Take AQUIPTA

Follow exactly the administration instructions for this medication as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.

How much to take

The recommended dose is 60 mg of atogepant once a day. Your doctor may instruct you to take a lower dose if:

  • you are taking other medications (listed in section 2);
  • you have severe kidney problems or are on dialysis.

How to take

AQUIPTA is administered orally. Do not break, crush, chew, or split the tablet before swallowing it. Tablets can be taken with or without food.

If you take more AQUIPTA than you should

If you take more tablets than you should, consult your doctor. You may experience some of the adverse effects listed in section 4.

If you forget to take AQUIPTA

  • If you forget a dose, take it as soon as you remember.
  • If you forget a dose for an entire day, skip the missed dose and take a regular dose the next day.
  • Do not take a double dose to make up for the missed dose.

If you interrupt treatment with AQUIPTA

Do not stop taking AQUIPTA without consulting your doctor first. Symptoms may recur if treatment is interrupted.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medications, this medication may produce adverse effects, although not everyone will experience them.

Severe Side Effects

Stop taking AQUIPTA and contact your doctor immediately if you experience any of the following symptoms, which may be part of a severe allergic reaction:

• difficulty breathing

• facial swelling

• rash, itching, or urticaria

Other Side Effects

Inform your doctor if you observe any of the following adverse effects:

Frequent(may affect up to 1 in 10 people):

  • nausea (urge to vomit);
  • constipation;
  • fatigue (tiredness);
  • drowsiness (tendency to sleep);
  • decreased appetite;
  • weight loss.

Infrequent(may affect up to 1 in 100 people):

  • increase in liver enzyme levels.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the national notification system included in theAppendix V. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.

5. Conservation of AQUIPTA

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the box and on the blister pack after EXP. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. In this way, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of AQUIPTA

AQUIPTA 10 mg tablets

  • The active ingredient is atogepant. Each tablet contains 10 mg of atogepant.
  • The other components are: copolymer of polyvinylpyrrolidone/vinyl acetate, polyethylene glycol succinate and vitamin E, mannitol, microcrystalline cellulose, sodium chloride, sodium croscarmellose, colloidal silicon dioxide and sodium stearoyl fumarate (see section 2).

AQUIPTA 60 mg tablets

  • The active ingredient is atogepant. Each tablet contains 60 mg of atogepant.
  • The other components are: copolymer of polyvinylpyrrolidone/vinyl acetate, polyethylene glycol succinate and vitamin E, mannitol, microcrystalline cellulose, sodium chloride, sodium croscarmellose, colloidal silicon dioxide and sodium stearoyl fumarate (see section 2).

Appearance of the product and contents of the package

AQUIPTA 10 mg tablets

The 10 mg AQUIPTA tablet is a biconvex, round, white to off-white tablet, with the inscription “A” and “10” on one side. It is available in packages containing 28 or 98 tablets.

AQUIPTA 60 mg tablets

The 60 mg AQUIPTA tablet is a biconvex, oval-shaped, white to off-white tablet, with the inscription “A60” on one side. It is available in packages containing 28 or 98 tablets.

Only some package sizes may be marketed.

Marketing authorization holder

AbbVie Deutschland GmbH & Co. KG

Knollstrasse

67061 Ludwigshafen

Germany

Responsible manufacturer

AbbVie S.r.l

S.R. 148 Pontina Km 52 Snc

Campoverde di Aprilia, Latina 04011

Italy

For more information about this medicine, please contact the local representative of the marketing authorization holder:

België/Belgique/Belgien

AbbVie SA

Tél/Tel: +32 10 477811

Lietuva

AbbVie UAB

Tel: +370 5 205 3023

Luxembourg/Luxemburg

AbbVie SA

Belgique/Belgien

Tél/Tel: +32 10 477811

Ceská republika

AbbVie s.r.o.

Tel: +420 233 098 111

Magyarország

AbbVie Kft.

Tel.:+36 1 455 8600

Danmark

AbbVie A/S

Tlf: +45 72 30-20-28

Malta

Vivian Corporation Ltd.

Tel: +356 27780331

Deutschland

AbbVie Deutschland GmbH & Co. KG

Tel: 00800 222843 33 (free of charge)

Tel: +49 (0) 611 / 1720-0

Nederland

AbbVie B.V.

Tel: +31 (0)88 322 2843

Eesti

AbbVie OÜ

Tel: +372 623 1011

Norge

AbbVie AS

Tlf: +47 67 81 80 00

Ελλ?δα

AbbVie ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε.

Τηλ: +30 214 4165 555

Österreich

AbbVie GmbH

Tel: +43 120589-0

España

AbbVie Spain, S.L.U.

Tel: +34 91 384 09 10

Polska

AbbVie Sp. z o.o.

Tel.: +48 22 372 78 00

France

AbbVie

Tél: +33 (0) 1 45 60 13 00

Portugal

AbbVie, Lda.

Tel: +351 (0)21 1908400

Hrvatska

AbbVie d.o.o.

Tel + 385 (0)1 5625 501

România

AbbVie S.R.L.

Tel: +40 21 529 30 35

Ireland

AbbVie Limited

Tel: +353 (0)1 4287900

Slovenija

AbbVie Biofarmacevtska družba d.o.o.

Tel: +386 (1)32 08 060

Ísland

Vistor hf.

Sími: +354 535 7000

Slovenská republika

AbbVie s.r.o.

Tel: +421 2 5050 0777

Italia

AbbVie S.r.l.

Tel: +39 06 928921

Suomi/Finland

AbbVie Oy

Puh/Tel: +358 (0)10 2411 200

Κúπρος

Lifepharma (Z.A.M.) Ltd

Τηλ.: +357 22 34 74 40

Sverige

AbbVie AB

Tel: +46 (0)8 684 44 600

Latvija

AbbVie SIA

Tel: +371 67605000

Last update of this leaflet:

Other sources of information

The detailed information on this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu/.

To listen to or request a copy of this leaflet in, or listen to it in , please contact the local representative of the marketing authorization holder.

Country of registration
Active substance
Prescription required
Yes
Composition
Manitol (e-421) (169,50 mg mg), Cloruro de sodio (65,20 mg mg), Croscarmelosa sodica (65,20 mg mg), Fumarato de estearilo y sodio (4,90 mg mg)
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.

Talk to a doctor online

Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.

5.01 review
Doctor

Anna Moret

Dermatology18 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for: • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis • Pediatric skin problems — from newborns to adolescents • Sexually transmitted infections (STIs) and dermatovenereology • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments • Skin allergies and hypersensitivity reactions • Mole checks, lesion evaluation, and skin cancer screening • Skincare advice and personalised cosmeceutical routines

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

CameraBook a video appointment
5.05 reviews
Doctor

Alina Tsurkan

Family medicine12 years of experience

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including: • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections • Chronic diseases: hypertension, diabetes, thyroid disorders, elevated cholesterol, weight management • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness • Women’s health: menstrual irregularities, perimenopausal symptoms, preventive screening • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance

She also provides: • IMT medical certificates for driving licence exchange in Portugal • Personalised preventive care and wellness consultations • Interpretation of test results and medical reports • Follow-up care and medication review • Support in managing multiple coexisting conditions • Remote prescription management and medical documentation

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

CameraBook a video appointment
5.04 reviews
Doctor

Andrei Popov

General medicine6 years of experience

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including: • Chronic pain lasting more than 3 months • Migraines and recurring headaches • Neck, back, lower back, and joint pain • Post-traumatic pain following injury or surgery • Nerve-related pain, fibromyalgia, and neuralgia In addition to pain management, Dr. Popov helps patients with: • Respiratory infections (colds, bronchitis, pneumonia) • High blood pressure and metabolic conditions such as diabetes • Preventive care and routine health check-ups

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

CameraBook a video appointment
5.03 reviews
Doctor

Yevgen Yakovenko

General surgery11 years of experience

Dr. Yevhenii Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise: • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan. • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions. • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies. • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries. • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required. • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up. • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data. • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications: • 12+ years of clinical experience in university hospitals in Germany and Spain • International education: Ukraine – Germany – Spain • Member of the German Society of Surgeons (BDC) • Certified in radiological diagnostics and robotic surgery • Active participant in international medical conferences and research

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

CameraBook a video appointment
See all doctors

Stay informed and save on care

Get health tips, platform updates, and exclusive promos for subscribers.

Follow us on social media
FacebookInstagramTikTok